In order to ascertain the incidence of monoclonal gammopathy (MG) in systemic lupus erythematosus (SLE), 120 SLE patients were evaluated. Four patients (3.3%), two of whom were under 50 years of age, were found to have a monoclonal immunoglobulin in their serum. Our data agree with the previous literature in demonstrating a higher incidence of MG in SLE patients in comparison with the general population. Neither the clinical importance nor the pathogenetic significance of this association is known.
Butler RC, Thomas SM, Thompson JM, Keat Acs.Anaplastic myeloma in systemic lupus erythematosus. Ann Rheum Dis1984; 43: 653-5.
3.
Powell FC, Greipp PR, Su WpdDiscoid lupus erythematosus and monoclonal gammopathy. Br J Dermatol1983; 109: 355-60.
4.
Axelsson U., Bachmann R., Hallen J.Frequency of pathological proteins (M-components) in 6995 sera from an adult population. Acta Med Scand1966; 179: 235-47.
5.
Kyle RA, Finkelstein S., Elveback LR et al. Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood1972; 40: 719-24.
6.
Saleun JP, Vicariot M., Deroff P. et al. Monoclonal gammopathies in the adult population of Finistere, France. J Clin Pathol1982; 35: 63-8.
7.
Martin M., Diaz-Rubio E., Enriquez LS et al. Incidencia y significado de la gammapatia monoclonal en una poblacion hospitalaria espanola. Med Clin (Barc)1983; 80: 433-7.
8.
Pruzanski W.Rheumatological disorders and monoclonal gammopathy - a new syndrome?Br J Rheumatol1987; 26: 406-8.
